Patent details

Basic Information

Publication number:

EP1181932

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP013069406

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Therapeutic compositions comprising excess enantiomer of amlodipine

French Title of Invention:

Composition thérapeutique contenant un excès d'énantiomère d'amlidopine

German Title of Invention:

Therapeutische Zusammensetzungen welche einen Überschuss eines Amlodipin-Enantiomers enthalten

SPC Number:

Dates

Filing date:

15/08/2001

Grant date:

27/06/2007

EP Publication Date:

27/06/2007

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

27/02/2002

EP B1 Publication Date:

27/06/2007

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

15/08/2007

Expiration date:

15/08/2021

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

15/08/2001

 

 

Name:

PFIZER INC.

Address:

235 East 42nd Street, New York, N.Y. 10017, United States (US)

Name:

Pfizer Limited

Address:

Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom (GB)

Inventor

1

Name:

Dodd Michael George

Address:

United Kingdom (GB)

2

Name:

Humphrey Michael John

Address:

United Kingdom (GB)

3

Name:

Chahwala Suresh Babubhai

Address:

United Kingdom (GB)

Priority

Priority Number:

0020842

Priority Date:

23/08/2000

Priority Country:

United Kingdom (GB)

Classification

Main IPC Class:

A61K 31/44;

Filing date	Document type	Number of pages